靶点名称: APBB2
NCBI ID: G323
<< 返回
Drug Target Analysis Report Drug Target Analysis Report Content
APBB2
其它名称: Amyloid beta precursor protein binding family B member 2 (isoform b) | Amyloid beta precursor protein binding family B member 2, transcript variant 2 | protein Fe65-like 1 | Amyloid-beta (A4) precursor protein-binding family B member 2 | Fe65-like protein | Amyloid beta precursor protein binding family B member 2, transcript variant 4 | Fe65-like 1 | FE65L1 | APBB2 variant 4 | Amyloid beta precursor protein binding family B member 2 | FE65L | APBB2 variant 3 | Amyloid beta precursor protein binding family B member 2, transcript variant 3 | Amyloid beta A4 precursor protein-binding family B member 2 | Amyloid beta precursor protein binding family B member 2 (isoform c) | Protein Fe65-like 1 | Amyloid-beta A4 precursor protein-binding family B member 2 | APBB2 variant 2 | APBB2_HUMAN | Amyloid beta A4 precursor protein-binding family B member 2 (APBB2) | Amyloid beta precursor protein binding family B member 2 (isoform d) | amyloid beta precursor protein binding family B member 2

APBB2是一种蛋白质,在正常情况下,它位于细胞核内

然而,当细胞受到某些刺激时,APBB2可以离开细胞核,并且参与到细胞信号传导的过程中。这一过程在细胞增殖、分化和肿瘤形成中起着重要的作用。

近年来,科学家们对APBB2的生物学功能进行了深入的研究,并且发现它在许多疾病中都发挥着重要的作用。例如,在癌症中,APBB2常常会发生变化,并且与癌症的进展和治疗反应密切相关。

此外,APBB2还被用作药物靶点。科学家们发现,APBB2在药物的干预下会发生改变,并且这些变化可以被利用来增强药物的疗效或者降低药物的毒性。这一发现为癌症的治疗带来了一种新的思路。

APBB2是一种非常重要的蛋白质,它在细胞信号传导和肿瘤形成中发挥着重要的作用。随着科学技术的不断发展,APBB2的研究也将继续深入,为人类的健康带来更多的希望。

《APBB2靶点/生物标志物调研报告》(Target / Biomarker Review Report)是利用AI技术对数百至数万篇相关科研文献进行综合分析,并经过专业人员严格审核后提供的可订制化的专业研究报告,报告涵盖与APBB2相关的特定信息,包括但不限于以下内容:
•   靶点/生物标志物基本信息;
•   蛋白结构及化合物结合;
•   蛋白生物学机制;
•   靶点/生物标志物重要性
•   靶点筛选与验证;
•   蛋白表达水平;
•   疾病相关性;
•   成药性;
•   相关联合用药;
•   药化试验;
•   相关专利分析;
•   靶点开发优势与风险...
研究报告有助于课题/项目申请、药物分子设计、研究进展汇报、研究论文发表、专利申请等。如果您希望获得该报告的完整版,请与我们联系: BD@silexon.ai

更多热门靶点分析

APBB3 | APC | APC2 | APCDD1 | APCDD1L | APCDD1L-DT | APCS | APEH | APELA | APEX1 | APEX2 | APH1A | APH1B | API5 | APIP | APLF | APLN | APLNR | APLP1 | APLP2 | APMAP | APOA1 | APOA1-AS | APOA2 | APOA4 | APOA5 | APOB | APOBEC1 | APOBEC2 | APOBEC3A | APOBEC3A_B | APOBEC3B | APOBEC3B-AS1 | APOBEC3C | APOBEC3D | APOBEC3F | APOBEC3G | APOBEC3H | APOBEC4 | APOBR | APOC1 | APOC1P1 | APOC2 | APOC3 | APOC4 | APOC4-APOC2 | APOD | APOE | APOF | APOH | APOL1 | APOL2 | APOL3 | APOL4 | APOL5 | APOL6 | APOLD1 | Apolipoprotein B mRNA editing complex | APOM | APOO | APOOL | APOOP2 | APOOP5 | APP | APP-BP | APPAT | APPBP2 | APPL1 | APPL2 | APRG1 | APRT | APTR | APTX | AQP1 | AQP10 | AQP11 | AQP12A | AQP12B | AQP2 | AQP3 | AQP4 | AQP4-AS1 | AQP5 | AQP6 | AQP7 | AQP7P1 | AQP7P2 | AQP7P3 | AQP7P5 | AQP8 | AQP9 | AQR | AR | ARAF | ARAP1 | ARAP1-AS2 | ARAP2 | ARAP3 | ARC | ARCN1